RP Bio Inc. (KOSDAQ:314140)
5,980.00
-90.00 (-1.48%)
At close: Sep 11, 2026
| Market Cap | 51.82B -9.5% |
| Revenue (ttm) | 141.42B +9.6% |
| Net Income | 6.73B +121.6% |
| EPS | 777.28 +121.2% |
| Shares Out | 8.67M |
| PE Ratio | 7.69 |
| Forward PE | n/a |
| Dividend | 50.00 (0.82%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 4,109 |
| Open | 6,060.00 |
| Previous Close | 6,070.00 |
| Day's Range | 5,920.00 - 6,060.00 |
| 52-Week Range | 4,810.00 - 9,130.00 |
| Beta | 0.42 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |